Giselle Almeida Gonzalez

Researcher

University of Arkansas for Medical Sciences

grad_student

1 h-index 3 pubs 4 cited

Is this your profile? Verify and claim your profile

Biography and Research Information

OverviewAI-generated summary

Giselle Almeida Gonzalez's research investigates the molecular mechanisms underlying pediatric acute megakaryoblastic leukemia (AML), specifically focusing on the CBFA2T3-GLIS2 fusion and its role in disease progression and therapeutic resistance. Her work has explored how this fusion reprograms enhancer-linked DNA methylation, leading to apoptotic resistance, and has identified this epigenetic vulnerability as a potential target for treatment. Almeida Gonzalez has also studied the epigenetic enhancement of MED12L in ETO2-GLIS2 positive pediatric AML and its association with resistance to CDK8 inhibitors. Her publications in this area highlight transcriptional rewiring driven by enhancer methylation in pediatric AML. Almeida Gonzalez collaborates with researchers including Samrat Roy Choudhury, Arundhati Chavan, Jason Farrar, and Troy Davidson at the University of Arkansas for Medical Sciences.

Metrics

  • h-index: 1
  • Publications: 3
  • Citations: 4

Selected Publications

  • Abstract PR006: CBFA2T3–GLIS2 fusion reprograms enhancer-linked DNA methylation to enforce apoptotic resistance and defines an epigenetic vulnerability in pediatric AML (2026) DOI
  • Transcriptional rewiring by enhancer methylation in CBFA2T3-GLIS2–driven pediatric acute megakaryoblastic leukemia (2025) DOI
  • Epigenetically Enhanced MED12L in ETO2-GLIS2 Positive Pediatric Acute Megakaryoblastic Leukemia Is Associated with Resistance to the CDK8 Inhibitors (2021) DOI

Collaborators

Researchers in the database who share publications

Similar Researchers

Based on overlapping research topics